What is the recommended dose of nifedipine (calcium channel blocker) for threatened preterm labor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nifedipine Dosing for Threatened Preterm Labor

For threatened preterm labor, the recommended initial dose of nifedipine is 10-20 mg orally, which can be repeated every 20 minutes if necessary up to a maximum of 40 mg in the first hour, followed by 20 mg every 4-6 hours for up to 72 hours. 1, 2

Initial Loading Dose

  • Immediate-release nifedipine should be administered orally at 10-20 mg initially 1, 2
  • If contractions continue, additional doses of 10 mg can be given every 15-20 minutes 1, 2
  • Maximum dosing in the first hour should not exceed 40 mg 1, 2
  • Nifedipine should be administered orally, not sublingually, as sublingual administration increases the risk of sudden hypotension 3

Maintenance Dosing

  • After successful initial tocolysis, maintenance dosing of 20 mg every 4-6 hours for up to 72 hours is recommended 1, 2
  • For extended tocolysis, slow-release nifedipine formulations can be used at doses of 60-80 mg daily 4, 5
  • Higher dose regimens (120-160 mg slow-release daily for 48 hours followed by 80-120 mg daily until 36 weeks) have been studied but don't show significant advantages in achieving uterine quiescence at 48 hours 4

Monitoring Requirements

  • Maternal blood pressure should be monitored closely, especially during the first hour of treatment, to minimize the risk of hypotension 3
  • The goal of tocolysis is to delay delivery for at least 48 hours to allow for corticosteroid administration for fetal lung maturity 3
  • Continuous fetal monitoring is recommended during the acute phase of treatment 1

Precautions and Contraindications

  • Nifedipine should be used with caution when combined with magnesium sulfate due to the risk of precipitous blood pressure drop 3, 6
  • Close monitoring is essential when using nifedipine in combination with magnesium sulfate 6
  • Nifedipine is not FDA-approved specifically for preterm labor management but is used off-label for this indication 3

Comparative Efficacy

  • Nifedipine has comparable efficacy to other tocolytics like terbutaline in delaying delivery for ≥48 hours 1
  • Nifedipine has fewer maternal side effects compared to beta-mimetics like terbutaline 1
  • Common side effects include headache, flushing, and dizziness 3

Alternative Approaches

  • If immediate-release nifedipine is not available and intravenous access has not been established, 200 mg of labetalol or 1.0-1.5 g of methyldopa can be administered orally 7, 6
  • For hypertensive emergencies in pregnancy, a different dosing regimen is used (10-20 mg short-acting nifedipine with possible repeat in 30 minutes) 7

Important Clinical Considerations

  • The efficacy of maintenance tocolysis with nifedipine beyond the initial 48-72 hours remains controversial, with some studies showing no significant reduction in adverse perinatal outcomes 5
  • Some research suggests that combining nifedipine with vaginal progesterone after successful initial tocolysis may significantly prolong pregnancy and improve neonatal outcomes 2
  • Short-acting nifedipine should be avoided for maintenance therapy in pregnancy as it can cause uncontrolled hypotension 8

References

Research

Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.

Journal of the Medical Association of Thailand =, Chotmaihet thangphaet.., 2007

Guideline

Nifedipine Dosing for Prevention of Preterm Labor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypertension in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nifedipine vs Amlodipine Safety in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.